Visit COVID-19 resources

[Skip to Content]

Blood flow velocity measured using the Retinal Function Imager predicts successful ranibizumab treatment in neovascular age-related macular degeneration: early prospective cohort study – (Eye 29, 630 (May 2015))

7 May 2015

This news item is available to RCOphth members only, please log in below to access.

Members Login